Two New Products (Ambroxol and Tirofiban) were issued MA by NMPA
In recent days, Ambroxol Hydrochloric Injection (4ml:30mg; 2ml:15mg; 1ml:7.5mg PP plastic ampoule) and Tirofiban Hydrochloric Injection (250ml and 100ml glass bottle) were issued Manufacture & Registration Authorization by NMPA.
As R & D’s introduction, by now Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Can supply Ambroxol in dosage of orally disintegrating, large volume injection, small volume injection to patients with respiratory disease for choices. And PP plastic ampoule is more safe and easier to use than glass ampoule. Tirofiban Hydrochloric Injection is one of cardiovascular drugs indicated for treatment of acute elevated coronary syndromes.